The journal’s Editor-in-Chief, Adrian Newland CBE, Professor of Hematology at Barts and The London School of Medicine, UK, commented: “This is a very exciting development for both Hematology and the ISH and we look forward to a long, fruitful and productive relationship.”
This partnership will be recognised immediately as representatives from the three divisions of the society join the international editorial board. Members of the Society will receive the journal at a discounted rate as part of their subscription.
Professor Saengsuree Jootar, Chair of the Council of the ISH is confident that the partnership will promote collaboration. “ISH members will have access to the journal as a membership benefit and will be encouraged to view the journal as an outlet for their published work. The ISH see this partnership as a vital step in the development of the Society over the next few years.”
The International Society of Hematology, founded in 1946, is a non-profit organization, concerned with advancing scientific research as well as the practice of hematology at both clinical and laboratory levels. ISH also looks after the interests of hematologists and hematology in its organization. ISH membership is open to any person with medical or scientific qualification of good professional standing with active interest in hematology for a period of at least 5 years. ISH has over 4,000 active members, worldwide. ISH hosts a successful biannual World Congress, by rotation within the three Divisions, to provide an international forum for discussion of hematological problems by contributing to the creation of an academic, scientific and research network in hematology. www.ishworld.org
Hematology is an international journal, publishing original and review articles in the field of general hematology, including oncology, pathology, biology, clinical research and epidemiology. Hematology aims to bridge the interests and practices of both those carrying out laboratory work and those whose main inclination is towards patient care. The journal provides a forum where the clinical aspects of any published material will be emphasized. Hematology is included in MEDLINE, Scopus and Science Citation Index and the 2009 Impact Factor is 1.333.
